Literature DB >> 17079736

Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.

Keisuke Horiuchi1, Sylvain Le Gall, Marc Schulte, Takafumi Yamaguchi, Karina Reiss, Gillian Murphy, Yoshiaki Toyama, Dieter Hartmann, Paul Saftig, Carl P Blobel.   

Abstract

Signaling via the epidermal growth factor receptor (EGFR), which has critical roles in development and diseases such as cancer, is regulated by proteolytic shedding of its membrane-tethered ligands. Sheddases for EGFR-ligands are therefore key signaling switches in the EGFR pathway. Here, we determined which ADAMs (a disintegrin and metalloprotease) can shed various EGFR-ligands, and we analyzed the regulation of EGFR-ligand shedding by two commonly used stimuli, phorbol esters and calcium influx. Phorbol esters predominantly activate ADAM17, thereby triggering a burst of shedding of EGFR-ligands from a late secretory pathway compartment. Calcium influx stimulates ADAM10, requiring its cytoplasmic domain. However, calcium influx-stimulated shedding of transforming growth factor alpha and amphiregulin does not require ADAM17, even though ADAM17 is essential for phorbol ester-stimulated shedding of these EGFR-ligands. This study provides new insight into the machinery responsible for EGFR-ligand release and thus EGFR signaling and demonstrates that dysregulated EGFR-ligand shedding may be caused by increased expression of constitutively active sheddases or activation of different sheddases by distinct stimuli.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079736      PMCID: PMC1751309          DOI: 10.1091/mbc.e06-01-0014

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  44 in total

Review 1.  Membrane-anchored growth factors.

Authors:  J Massagué; A Pandiella
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

2.  Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2.

Authors:  Keisuke Horiuchi; Hong-Ming Zhou; Kristine Kelly; Katia Manova; Carl P Blobel
Journal:  Dev Biol       Date:  2005-07-15       Impact factor: 3.582

3.  A role for ADAM12 in breast tumor progression and stromal cell apoptosis.

Authors:  Marie Kveiborg; Camilla Fröhlich; Reidar Albrechtsen; Verena Tischler; Nikolaj Dietrich; Peter Holck; Pauliina Kronqvist; Fritz Rank; Arthur M Mercurio; Ulla M Wewer
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

4.  Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.

Authors:  P Reddy; J L Slack; R Davis; D P Cerretti; C J Kozlosky; R A Blanton; D Shows; J J Peschon; R A Black
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

5.  Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme.

Authors:  J R Doedens; R A Black
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

6.  ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression.

Authors:  L Peduto; V E Reuter; A Sehara-Fujisawa; D R Shaffer; H I Scher; C P Blobel
Journal:  Oncogene       Date:  2006-04-10       Impact factor: 9.867

7.  Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE).

Authors:  J Schlöndorff; J D Becherer; C P Blobel
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

8.  Recycling of cell surface pro-transforming growth factor-{alpha} regulates epidermal growth factor receptor activation.

Authors:  Sonia Martínez-Arca; Joan Josep Bech-Serra; Miguel Hurtado-Küttner; Aldo Borroto; Joaquín Arribas
Journal:  J Biol Chem       Date:  2005-08-29       Impact factor: 5.157

9.  Critical function for ADAM9 in mouse prostate cancer.

Authors:  Lucie Peduto; Victor E Reuter; David R Shaffer; Howard I Scher; Carl P Blobel
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

10.  Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.

Authors:  Mark D Sternlicht; Susan W Sunnarborg; Hosein Kouros-Mehr; Ying Yu; David C Lee; Zena Werb
Journal:  Development       Date:  2005-08-03       Impact factor: 6.868

View more
  146 in total

1.  Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).

Authors:  Marie Kveiborg; Jonas Jacobsen; Meng-Huee Lee; Hideaki Nagase; Ulla M Wewer; Gillian Murphy
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

2.  Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro.

Authors:  Juan Li; Bin Liu; Xiaofei Gao; Zhixing Ma; Tianyi CaoSong; Yan-ai Mei; Yufang Zheng
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

3.  Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.

Authors:  Gillian Murphy
Journal:  Int J Exp Pathol       Date:  2010-08       Impact factor: 1.925

Review 4.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

5.  Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes.

Authors:  Gisela Weskamp; Karen Mendelson; Steve Swendeman; Sylvain Le Gall; Yan Ma; Stephen Lyman; Akinari Hinoki; Satoru Eguchi; Victor Guaiquil; Keisuke Horiuchi; Carl P Blobel
Journal:  Circ Res       Date:  2010-01-28       Impact factor: 17.367

6.  CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes.

Authors:  Joel A Mathews; David R Gibb; Bing-Hung Chen; Peggy Scherle; Daniel H Conrad
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

Review 7.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

8.  High-throughput protease activity cytometry reveals dose-dependent heterogeneity in PMA-mediated ADAM17 activation.

Authors:  Lidan Wu; Allison M Claas; Aniruddh Sarkar; Douglas A Lauffenburger; Jongyoon Han
Journal:  Integr Biol (Camb)       Date:  2015-04-02       Impact factor: 2.192

9.  Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.

Authors:  Miles A Miller; Layla Barkal; Karen Jeng; Andreas Herrlich; Marcia Moss; Linda G Griffith; Douglas A Lauffenburger
Journal:  Integr Biol (Camb)       Date:  2010-12-23       Impact factor: 2.192

10.  A protease storm cleaves a cell-cell adhesion molecule in cancer: multiple proteases converge to regulate PTPmu in glioma cells.

Authors:  Polly J Phillips-Mason; Sonya E L Craig; Susann M Brady-Kalnay
Journal:  J Cell Biochem       Date:  2014-09       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.